Makoto Okabe
Director/Board Member at NORITAKE CO., LIMITED
Profile
Makoto Okabe is currently a Director & Senior Managing Executive Officer at Noritake Co., Ltd.
since 2023.
Prior to this, Mr. Okabe was a Director at ImmunoFrontier, Inc.
Makoto Okabe active positions
| Companies | Position | Start |
|---|---|---|
| NORITAKE CO., LIMITED | Director/Board Member | 2023-06-22 |
Former positions of Makoto Okabe
| Companies | Position | End |
|---|---|---|
ImmunoFrontier, Inc.
 ImmunoFrontier, Inc. Miscellaneous Commercial ServicesCommercial Services ImmunoFrontier, Inc. is a holding company that specializes in the research and development of cancer vaccines. It develops CHP cancer protein vaccines and multifunctional cancer DNA vaccines. The firm also establishes technology solutions for promoting the creation of cancer DNA vaccines and therapeutics for immune diseases. The company was founded by Shiku Hiroshi on October 5, 2004 and is headquartered in Tokyo, Japan. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| NORITAKE CO., LIMITED | Producer Manufacturing |
| Private companies | 1 |
|---|---|
ImmunoFrontier, Inc.
ImmunoFrontier, Inc. Miscellaneous Commercial ServicesCommercial Services ImmunoFrontier, Inc. is a holding company that specializes in the research and development of cancer vaccines. It develops CHP cancer protein vaccines and multifunctional cancer DNA vaccines. The firm also establishes technology solutions for promoting the creation of cancer DNA vaccines and therapeutics for immune diseases. The company was founded by Shiku Hiroshi on October 5, 2004 and is headquartered in Tokyo, Japan. | Commercial Services |
- Stock Market
- Insiders
- Makoto Okabe
